
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
[SAGE] Sage Therapeutics Inc - Depreciation & Amortization
Data updated 2023-Sep-10 (Sunday)Note: Detailed Statistics for Depreciation & Amortization in Income Statement for Sage Therapeutics Inc [NASDAQ:SAGE] with frequency distribution chart that analyze trends & history . Depreciation & Amortization are non-cash expenses that account for productivity decay of assets (like buildings, equipment etc.). View Income Statement for broader context
Share
Quarterly Depreciation & Amortization values for Sage Therapeutics Inc are rounded to enhance readability
2023-Jun | 2023-Mar | 2022-Dec | 2022-Sep | 2022-Jun | 2022-Mar | |
---|---|---|---|---|---|---|
Depreciation & Amortization | 331 K | 323 K | 290 K | 278 K | 279 K | 275 K |
Sequential Quarter Growth | +2.5% | +11.4% | +4.3% | -0.4% | +1.5% | -17.4% |
Quarter-on Quarter Growth | +18.6% | +17.5% | -12.9% | -30.5% | -69.0% | -89.4% |
Annual Depreciation & Amortization values for Sage Therapeutics Inc are rounded to enhance readability
2022-Dec | 2022-Jan | 2021-Jan | 2020-Jan | 2019-Jan | 2018-Jan | |
---|---|---|---|---|---|---|
Depreciation & Amortization | 1 M | 4.18 M | 4 M | 3 M | 2 M | 1 M |
Year-on-Year Growth | -76.1% | +4.6% | +33.3% | +50.0% | +100.0% | +Inf% |
2-yr CAGR | -50.0% | +18.1% | +41.4% | +73.2% | ||
3-yr CAGR | -30.7% | +27.9% | +58.7% | |||
4-yr CAGR | -15.9% | +43.0% | ||||
5-yr CAGR | 0.0% |
Frequency distribution of quarterly Depreciation & Amortization values from 2016-Dec-31 grouped into buckets. Latest Depreciation & Amortization value is 331 Thousand as of 2023-Jun-30
Subsequent stock performance post earnings date till next announcement for Sage Therapeutics Inc mapped with quarterly Depreciation & Amortization values reported at that time. Most recent value denoted with star
Select frequency and calculation type for Depreciation & Amortization above for vertical axis in scatter chart. Additionally choose type of performance for horizontal axis
Bayesian (Conditional Probability) analysis for Sage Therapeutics Inc with subsequent post-earnings performance given Depreciation & Amortization values. Analysis uses quarterly data and subsequent absolute performance. Most recent quarter is denoted with a star and corresponding partial performance is excluded from calculations
Underperform (absolute perf.) | Outperform (absolute perf.) | |
---|---|---|
Depreciation & Amortization - Low | 33% | 67% |
Depreciation & Amortization - Medium | 56% | 44% |
Depreciation & Amortization - High | 63% | 38% |
Depreciation & Amortization (Sequential growth %) - Low | 56% | 44% |
Depreciation & Amortization (Sequential growth %) - Medium | 63% | 38% |
Depreciation & Amortization (Sequential growth %) - High | 38% | 63% |
Depreciation & Amortization (QoQ growth %) - Low | 38% | 63% |
Depreciation & Amortization (QoQ growth %) - Medium | 71% | 29% |
Depreciation & Amortization (QoQ growth %) - High | 57% | 43% |
Related to Sage Therapeutics Inc
Information for Sage Therapeutics Inc
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers Currently Viewing
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-30 on Google
SEC Reports : Quarterly reports around 2025-May-30 on SEC Edgar
Compare Sage Therapeutics Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Sage Therapeutics Inc
Industry : Biotechnology industry performance which includes Sage Therapeutics Inc